For the quarter ending 2025-09-30, HNGE had -$39,442K decrease in cash & cash equivalents over the period. $107,248K in free cash flow.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net income (loss) | -560,356 | - |
| Depreciation and amortization | 3,910 | - |
| Stock-based compensation | 625,837 | - |
| Amortization of deferred commissions | 32,436 | - |
| Accretion of discounts and amortization of premiums on marketable securities, net | -376 | - |
| Non-cash operating lease expense | 2,549 | - |
| Provision for credit losses | 3,340 | - |
| Deferred income taxes | 146 | - |
| Other | -2 | - |
| Accounts receivable | 47,610 | - |
| Deferred commissions | -38,320 | - |
| Inventory | 2,939 | - |
| Prepaid expenses and other current assets | 8,002 | - |
| Other assets | 8,149 | - |
| Accounts payable and accrued liabilities | 24,990 | - |
| Operating lease liabilities | -2,724 | - |
| Deferred revenue | 82,062 | - |
| Net cash provided by operating activities | 107,548 | - |
| Purchase of property and equipment | 300 | - |
| Capitalized internal use software | 3,401 | - |
| Purchases of marketable securities | 318,180 | - |
| Maturities of marketable securities | 249,814 | - |
| Acquisition of a business | 4,000 | - |
| Net cash (used in) provided by investing activities | -76,067 | - |
| Proceeds from exercise of common stock options | 787 | - |
| Proceeds from issuance of common stock in initial public offering, net of issuance costs | 255,675 | - |
| Tax withholdings on settlement of restricted stock units and performance-based restricted stock units | 272,258 | - |
| Payment on repurchase agreement with coatue | 50,000 | - |
| Proceeds from repayment of non-recourse loans to employees | 4,934 | - |
| Payments for deferred offering costs | 10,061 | - |
| Net cash (used in) provided by financing activities | -70,923 | - |
| Restricted cash | - | 1,802 |
| Net increase (decrease) in cash | -39,442 | - |
| Cash and cash equivalents | - | 237,170 |
| Cash and cash equivalents at beginning of period | 302,586 | - |
| Cash and cash equivalents at end of period | 263,144 | 238,972 |
Hinge Health, Inc. (HNGE)
Hinge Health, Inc. (HNGE)